Key result
Higher inflammatory markers in HIV+ men linked to up to ~60% more significant coronary stenosis.
Why the study?
Are inflammatory markers associated with subclinical coronary artery disease in HIV+ men?
Cohort (n=923)
Yes
Are inflammatory markers associated with subclinical coronary artery disease in HIV+ men?
Absolute Event Rate: 63% vs 54%
p-value: p=0.02
Higher levels of inflammatory markers are associated with a greater prevalence of coronary stenosis and noncalcified plaque in HIV+ men, suggesting a role for inflammation in HIV-related coronary artery disease.
Supports inflammation's role in HIV-CAD; hypothesis-generating for targeted therapies pending RCTs.
BACKGROUND: Despite evidence for higher risk of coronary artery disease among HIV+ individuals, the underlying mechanisms are not well understood. We investigated associations of inflammatory markers with subclinical coronary artery disease in 923 participants of the Multicenter AIDS Cohort Study (575 HIV+ and 348 HIV- men) who underwent noncontrast computed tomography scans for coronary artery calcification, the majority (n=692) also undergoing coronary computed tomography angiography. METHODS AND RESULTS: Outcomes included presence and extent of coronary artery calcification, plus computed tomography angiography analysis of presence, composition, and extent of coronary plaques and severity of coronary stenosis. HIV+ men had significantly higher levels of interleukin-6 (IL-6), intercellular adhesion molecule-1, C-reactive protein, and soluble-tumor necrosis factor-α receptor (sTNFαR) I and II (all P<0.01) and a higher prevalence of noncalcified plaque (63% versus 54%, P=0.02) on computed tomography angiography. Among HIV+ men, for every SD increase in log-interleukin-6 and log intercellular adhesion molecule-1, there was a 30% and 60% increase, respectively, in the prevalence of coronary stenosis ≥50% (all P<0.05). Similarly, sTNFαR I and II in HIV+ participants were associated with an increase in prevalence of coronary stenosis ≥70% (P<0.05). Higher levels of interleukin-6, sTNFαR I, and sTNFαR II were also associated with greater coronary artery calcification score in HIV+ men (P<0.01). CONCLUSIONS: Higher inflammatory marker levels are associated with greater prevalence of coronary stenosis in HIV+ men. Our findings underscore the need for further study to elucidate the relationships of inflammatory pathways with coronary artery disease in HIV+ individuals.
No takes yet. Share an insight, caveat, or question.
Bahrami et al. (2016) conducted a cohort in Subclinical coronary artery disease in HIV (n=923). Inflammatory markers (IL-6, ICAM-1, CRP, sTNFαR I and II) vs. HIV- men was evaluated on Presence of noncalcified plaque on computed tomography angiography (p=0.02). Higher levels of inflammatory markers like IL-6 and ICAM-1 in HIV+ men were associated with a 30% and 60% increase, respectively, in the prevalence of coronary stenosis ≥50% (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: